These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9805981)

  • 21. Present and future of 5-HT receptor agonists as antimigraine drugs.
    Pauwels PJ; John GW
    Clin Neuropharmacol; 1999; 22(3):123-36. PubMed ID: 10367177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
    Laloux P; Vakaet A; Monseu G; Jacquy J; Bourgeois P; van der Linden C
    Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rizatriptan. Convenience and consistency.
    Evans RW
    Postgrad Med; 2000 Sep; 108(3 Suppl):10-5. PubMed ID: 19667525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rizatriptan in the treatment of migraine.
    Dahlof CG; Rapoport AM; Sheftell FD; Lines CR
    Clin Ther; 1999 Nov; 21(11):1823-36; discussion 1821. PubMed ID: 10890255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.
    Savani N; Brautaset NJ; Reunanen M; Szirmai I; Ashford EA; Hassani H; Saiers J
    Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P; Landy S; Richardson M; Ames M
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of migraine--no longer a headache.
    Bhagat K; Kalangu KK
    Cent Afr J Med; 1999 Oct; 45(10):277-80. PubMed ID: 10823233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic comparison of oral triptans for management of acute migraine: implications for managed care.
    Reeder CE; Steadman S; Goldfarb SD
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S80-4. PubMed ID: 11859908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device.
    Luthringer R; Djupesland PG; Sheldrake CD; Flint A; Boeijinga P; Danjou P; Demazières A; Hewson G
    J Pharm Pharmacol; 2009 Sep; 61(9):1219-28. PubMed ID: 19703372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients].
    Pascual J; Navarro A; Caminero AB; Jurado C; Díaz-Insa S; Huerta M
    Neurologia; 2006 May; 21(4):188-91. PubMed ID: 16832773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians.
    Lipton RB; Cutrer FM; Goadsby PJ; Ferrari MD; Dodick DW; McCrory D; Liberman JN; Williams P
    Curr Med Res Opin; 2005 Mar; 21(3):413-24. PubMed ID: 15811210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack.
    Linde M; Mellberg A; Dahlöf C
    Cephalalgia; 2006 Feb; 26(2):113-21. PubMed ID: 16426264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rizatriptan versus usual care in long-term treatment of migraine.
    Silberstein SD
    Neurology; 2000; 55(9 Suppl 2):S25-8. PubMed ID: 11089516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of palatal myoclonus with sumatriptan.
    Scott BL; Evans RW; Jankovic J
    Mov Disord; 1996 Nov; 11(6):748-51. PubMed ID: 8914109
    [No Abstract]   [Full Text] [Related]  

  • 35. Abdominal migraine. This incapacitating disorder is still a mystery.
    Churak JM; Churak MM
    Adv NPs PAs; 2012 Mar; 3(3):31-4. PubMed ID: 22685840
    [No Abstract]   [Full Text] [Related]  

  • 36. [Migraine. Pharmacologic commentary on drugs for the treatment of migraine].
    Ziegler A
    Med Monatsschr Pharm; 1987 May; 10(5):139-52. PubMed ID: 3600490
    [No Abstract]   [Full Text] [Related]  

  • 37. Complicated migraine and migraine variants.
    Rothner AD
    Curr Pain Headache Rep; 2002 Jun; 6(3):233-9. PubMed ID: 12003695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Classification, diagnosis and treatment of chronic migraine: review of new data].
    Artemenko AR; Kurenkov AL; Belomestova KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(11):91-6. PubMed ID: 24429956
    [No Abstract]   [Full Text] [Related]  

  • 39. [Migraine. Classification and examination].
    Jensen K
    Ugeskr Laeger; 1998 Jul; 160(30):4399-402. PubMed ID: 9691829
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacologic management of migraine.
    Dowson AJ; Cady RK; Tepper SJ; Smith TR; Shapero G
    Ann Intern Med; 2004 Mar; 140(6):W26. PubMed ID: 15023737
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.